LifeScan, Inc.

Read the original:
LifeScan Recalls Specific Lots of Consumer and Professional OneTouch® SureStep® Test Strips Due To Inaccurate

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

Read the rest here: 
FDA Approves New Treatment for Type 2 Diabetes

People with pre-diabetes have higher than normal levels of blood glucose, a form of sugar the body uses for energy. Pre-diabetes, also called impaired fasting glucose or impaired glucose tolerance, can lead to type 2 diabetes, heart disease, and stroke. Preventive measures include weight loss, behavior modification, and glucose-lowering drugs.

View original here: 
Chinese Herbal Medicine May Benefit People With Pre-Diabetes, But Evidence Is Inconclusive

The U.S.

Go here to read the rest: 
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems

The U.S. Food and Drug Administration and WebMD Health Corp.

Go here to read the rest: 
FDA and WebMD Expand Consumer Health Information Partnership

The U.S. Food and Drug Administration today approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults

Originally posted here: 
FDA Approves New Drug Treatment for Type 2 Diabetes

FDA reviewing safety data regarding possible risk for cancer in patient with diabetes.

Original post: 
Lantus (insulin glargine)

About 47 million Americans have some form of metabolic syndromea group of conditions that increase the risk of diabetes, heart disease, and related complications. Metabolic syndrome is often characterized by abdominal obesity, impaired fasting glucose (an increase in glucose levels), elevated blood pressure, and high cholesterol and triglycerides. It is also associated with insulin resistance, a condition in which the body cannot use insulin effectively.

Original post: 
Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Adults